Ectopic lymphoid neogenesis and lymphoid chemokines in Sjogren's syndrome: At the interplay between chronic inflammation, autoimmunity and lymphomagenesis

Current Pharmaceutical Biotechnology

Volumn 13, Issue 10, 2012, Pages 1989-1996

  Bombardieri, Michele ^a   Pitzalis, Costantino ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Activation induced cytidine deaminase; Autoantibodies; Ectopic lymphoid structures; Lymphoid chemokines; Lymphomagenesis; Sjogren's syndrome

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SECONDARY LYMPHOID TISSUE CHEMOKINE;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; B CELL LYMPHOMA; CARCINOGENESIS; CELL STRUCTURE; CHRONIC INFLAMMATION; HUMAN; LYMPHOID CELL; NONHUMAN; ORGANOGENESIS; PROTEIN EXPRESSION; REVIEW; SALIVARY GLAND; SJOEGREN SYNDROME;

AUTOANTIBODIES; AUTOIMMUNITY; CHEMOKINES; CHORISTOMA; CHRONIC DISEASE; CYTIDINE DEAMINASE; HUMANS; INFLAMMATION; LYMPHOID TISSUE; LYMPHOMA, B-CELL, MARGINAL ZONE; SJOGREN'S SYNDROME;

ANIMALIA;

EID: 84866537988     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112802273209     Document Type: Review

References (78)

1. Chisholm, D. M.; Mason, D. K. Labial salivary gland biopsy in Sjogren's disease. J. Clin. Pathol., 1968, 21(5), 656-660.
2. Voulgarelis, M.; Moutsopoulos, H. M. Lymphoproliferation in autoimmunity and Sjogren's syndrome. Curr. Rheumatol. Rep., 2003, 5(4), 317-323.
3. Stott, D. I.; Hiepe, F.; Hummel, M.; Steinhauser, G.; Berek, C. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjogren's syndrome. J. Clin. Invest., 1998, 102(5), 938-946.
4. Routsias, J. G.; Tzioufas, A. G.; Moutsopoulos, H. M. The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases. Clin. Chim. Acta, 2004, 340(1-2), 1-25.
5. Dawson, L. J.; Stanbury, J.; Venn, N.; Hasdimir, B.; Rogers, S. N.; Smith, P. M. Antimuscarinic antibodies in primary Sjogren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum., 2006, 54(4), 1165-1173.
6. Humphreys-Beher, M. G.; Peck, A. B. New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model. Arch. Oral Biol., 1999, 44(Suppl 10), S21-S25.
7. Vitali, C.; Bombardieri, S.; Jonsson, R.; Moutsopoulos, H. M.; Alexander, E. L.; Carsons, S. E.; Daniels, T. E.; Fox, P. C.; Fox, R. I.; Kassan, S. S.; Pillemer, S. R.; Talal, N.; Weisman, M. H. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis., 2002, 61(6), 554-558.
8. Link, A.; Vogt, T. K.; Favre, S.; Britschgi, M. R.; cha-Orbea, H.; Hinz, B.; Cyster, J. G.; Luther, S. A. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat. Immunol., 2007, 8(11), 1255-1265.
9. Carlsen, H. S.; Haraldsen, G.; Brandtzaeg, P.; Baekkevold, E. S. Disparate lymphoid chemokine expression in mice and men: no evidence of CCL21 synthesis by human high endothelial venules. Blood, 2005, 106(2), 444-446.
10. Su, T. T.; Guo, B.; Wei, B.; Braun, J.; Rawlings, D. J. Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol. Rev., 2004, 197 161-178.
11. Cinamon, G.; Matloubian, M.; Lesneski, M. J.; Xu, Y.; Low, C.; Lu, T.; Proia, R. L.; Cyster, J. G. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat. Immunol., 2004, 5(7), 713-720.
12. Gunn, M. D.; Ngo, V. N.; Ansel, K. M.; Ekland, E. H.; Cyster, J. G.; Williams, L. T. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature, 1998, 391(6669), 799-803.
13. Cinamon, G.; Zachariah, M. A.; Lam, O. M.; Foss, F. W., Jr.; Cyster, J. G. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat. Immunol., 2008, 9(1), 54-62.
14. Sallusto, F.; Lanzavecchia, A. Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur. J. Immunol., 2009, 39(8), 2076-2082.
15. King, C.; Tangye, S. G.; Mackay, C. R. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu. Rev. Immunol., 2008, 26 741-766.
16. Mebius, R. E. Organogenesis of lymphoid tissues. Nat. Rev. Immunol., 2003, 3(4), 292-303.
17. Kim, M. Y.; Rossi, S.; Withers, D.; McConnell, F.; Toellner, K. M.; Gaspal, F.; Jenkinson, E.; Anderson, G.; Lane, P. J. Heterogeneity of lymphoid tissue inducer cell populations present in embryonic and adult mouse lymphoid tissues. Immunology, 2008, 124(2), 166-174.
18. Browning, J. L.; Allaire, N.; Ngam-Ek, A.; Notidis, E.; Hunt, J.; Perrin, S.; Fava, R. A. Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity, 2005, 23(5), 539-550.
19. Ngo, V. N.; Korner, H.; Gunn, M. D.; Schmidt, K. N.; Riminton, D. S.; Cooper, M. D.; Browning, J. L.; Sedgwick, J. D.; Cyster, J. G. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med., 1999, 189(2), 403-412.
20. Chen, S. C.; Vassileva, G.; Kinsley, D.; Holzmann, S.; Manfra, D.; Wiekowski, M. T.; Romani, N.; Lira, S. A. Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J. Immunol., 2002, 168(3), 1001-1008.
21. Luther, S. A.; Lopez, T.; Bai, W.; Hanahan, D.; Cyster, J. G. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity, 2000, 12(5), 471-481.
22. Luther, S. A.; Bidgol, A.; Hargreaves, D. C.; Schmidt, A.; Xu, Y.; Paniyadi, J.; Matloubian, M.; Cyster, J. G. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol., 2002, 169(1), 424-433.
23. Aziz, K. E.; McCluskey, P. J.; Wakefield, D. Characterisation of follicular dendritic cells in labial salivary glands of patients with primary Sjogren syndrome: comparison with tonsillar lymphoid follicles. Ann. Rheum. Dis., 1997, 56(2), 140-143.
24. Jonsson, M. V.; Skarstein, K.; Jonsson, R.; Brun, J. G. Serological implications of germinal center-like structures in primary Sjogren's syndrome. J. Rheumatol., 2007, 34(10), 2044-2049.
25. Barone, F.; Bombardieri, M.; Manzo, A.; Blades, M. C.; Morgan, P. R.; Challacombe, S. J.; Valesini, G.; Pitzalis, C. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome. Arthritis Rheum., 2005, 52(6), 1773-1784.
26. Aloisi, F.; Pujol-Borrell, R. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol., 2006, 6(3), 205-217.
27. Drayton, D. L.; Liao, S.; Mounzer, R. H.; Ruddle, N. H. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol., 2006, 7(4), 344-353.
28. Lee, Y. J.; Scofield, R. H.; Hyon, J. Y.; Yun, P. Y.; Lee, H. J.; Lee, E. Y.; Lee, E. B.; Song, Y. W. Salivary chemokine levels in pa tients with primary Sjogren's syndrome. Rheumatology (Oxford), 2010, 49(9), 1747-1752.
29. Tornwall, J.; Lane, T. E.; Fox, R. I.; Fox, H. S. T cell attractant chemokine expression initiates lacrimal gland destruction in nonobese diabetic mice. Lab. Invest., 1999, 79(12), 1719-1726.
30. Ogawa, N.; Ping, L.; Zhenjun, L.; Takada, Y.; Sugai, S. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjogren's syndrome. Arthritis Rheum., 2002, 46(10), 2730-2741.
31. Bombardieri, M.; Barone, F.; Pittoni, V.; Alessandri, C.; Conigliaro, P.; Blades, M. C.; Priori, R.; McInnes, I. B.; Valesini, G.; Pitzalis, C. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjogren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res. Ther., 2004, 6(5), R447-R456.
32. Xanthou, G.; Polihronis, M.; Tzioufas, A. G.; Paikos, S.; Sideras, P.; Moutsopoulos, H. M. "Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjogren's syndrome patients: possible participation in lymphoid structure formation. Arthritis Rheum., 2001, 44(2), 408-418.
33. Amft, N.; Curnow, S. J.; Scheel-Toellner, D.; Devadas, A.; Oates, J.; Crocker, J.; Hamburger, J.; Ainsworth, J.; Mathews, J.; Salmon, M.; Bowman, S. J.; Buckley, C. D. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren's syndrome. Arthritis Rheum., 2001, 44(11), 2633-2641.
34. Baekkevold, E. S.; Yamanaka, T.; Palframan, R. T.; Carlsen, H. S.; Reinholt, F. P.; von Andrian, U. H.; Brandtzaeg, P.; Haraldsen, G. The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J. Exp. Med., 2001, 193(9), 1105-1112.
35. Salomonsson, S.; Jonsson, M. V.; Skarstein, K.; Brokstad, K. A.; Hjelmstrom, P.; Wahren-Herlenius, M.; Jonsson, R. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome. Arthritis Rheum., 2003, 48(11), 3187-3201.
36. Carlsen, H. S.; Baekkevold, E. S.; Morton, H. C.; Haraldsen, G.; Brandtzaeg, P. Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood, 2004, 104(10), 3021-3027.
37. Manzo, A.; Vitolo, B.; Humby, F.; Caporali, R.; Jarrossay, D.; Dell'accio, F.; Ciardelli, L.; Uguccioni, M.; Montecucco, C.; Pitzalis, C. Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint. Arthritis Rheum., 2008, 58(11), 3377-3387.
38. Barone, F.; Bombardieri, M.; Rosado, M. M.; Morgan, P. R.; Challacombe, S. J.; De, V. S.; Carsetti, R.; Spencer, J.; Valesini, G.; Pitzalis, C. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization. J. Immunol., 2008, 180(7), 5130-5140.
39. Dorner, T.; Radbruch, A. Selecting B cells and plasma cells to memory. J. Exp. Med., 2005, 201(4), 497-499.
40. Manser, T. Textbook germinal centers? J. Immunol., 2004, 172(6), 3369-3375.
41. Muramatsu, M.; Sankaranand, V. S.; Anant, S.; Sugai, M.; Kinoshita, K.; Davidson, N. O.; Honjo, T. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem., 1999, 274 (26), 18470-18476.
42. Honjo, T.; Kinoshita, K.; Muramatsu, M. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu. Rev. Immunol., 2002, 20 165-196.
43. Pham, P.; Bransteitter, R.; Petruska, J.; Goodman, M. F. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature, 2003, 424(6944), 103-107.
44. Barreto, V.; Reina-San-Martin, B.; Ramiro, A. R.; McBride, K. M.; Nussenzweig, M. C. C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion. Mol. Cell, 2003, 12(2), 501-508.
45. Gellrich, S.; Rutz, S.; Borkowski, A.; Golembowski, S.; Gromnica-Ihle, E.; Sterry, W.; Jahn, S. Analysis of V(H)-D-J(H) gene transcripts in B cells infiltrating the salivary glands and lymph node tissues of patients with Sjogren's syndrome. Arthritis Rheum., 1999, 42(2), 240-247.
46. Jacobi, A. M.; Hansen, A.; Kaufmann, O.; Pruss, A.; Burmester, G. R.; Lipsky, P. E.; Dorner, T. Analysis of immunoglobulin light chain rearrangements in the salivary gland and blood of a patient with Sjogren's syndrome. Arthritis Res., 2002, 4(4), R4.
47. Bombardieri, M.; Barone, F.; Humby, F.; Kelly, S.; McGurk, M.; Morgan, P.; Challacombe, S.; De, V. S.; Valesini, G.; Spencer, J.; Pitzalis, C. Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjogren's syndrome. J. Immunol., 2007, 179(7), 4929-4938.
48. Schroder, A. E.; Greiner, A.; Seyfert, C.; Berek, C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc. Natl. Acad. Sci. U. S. A, 1996, 93(1), 221-225.
49. Muramatsu, M.; Sankaranand, V. S.; Anant, S.; Sugai, M.; Kinoshita, K.; Davidson, N. O.; Honjo, T. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem., 1999, 274(26), 18470-18476.
50. Liu, Y. J.; Xu, J.; de Bouteiller, O.; Parham, C. L.; Grouard, G.; Djossou, O.; Saint-Vis, B.; Lebecque, S.; Banchereau, J.; Moore, K. W. Follicular dendritic cells specifically express the long CR2/CD21 isoform. J. Exp. Med., 1997, 185(1), 165-170.
51. Humby, F.; Bombardieri, M.; Manzo, A.; Kelly, S.; Blades, M. C.; Kirkham, B.; Spencer, J.; Pitzalis, C. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS. Med., 2009, 6(1), e1.
52. Thaunat, O.; Patey, N.; Gautreau, C.; Lechaton, S.; Fremeaux-Bacchi, V.; eu-Nosjean, M. C.; Cassuto-Viguier, E.; Legendre, C.; Delahousse, M.; Lang, P.; Michel, J. B.; Nicoletti, A. B cell survival in intragraft tertiary lymphoid organs after rituximab therapy. Transplantation, 2008, 85(11), 1648-1653.
53. Astorri, E.; Bombardieri, M.; Gabba, S.; Peakman, M.; Pozzilli, P.; Pitzalis, C. Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets. J. Immunol., 2010, 185(6), 3359-3368.
54. Le, P. L.; Devauchelle, V.; Fautrel, A.; Daridon, C.; Saraux, A.; Youinou, P.; Pers, J. O. Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells. J. Immunol., 2009, 182(6), 3540-3547.
55. Ekland, E. H.; Forster, R.; Lipp, M.; Cyster, J. G. Requirements for follicular exclusion and competitive elimination of autoantigenbinding B cells. J. Immunol., 2004, 172(8), 4700-4708.
56. Ekstrom, S. K.; Vajdic, C. M.; Falster, M.; Engels, E. A.; Martinez-Maza, O.; Turner, J.; Hjalgrim, H.; Vineis, P.; Seniori, C. A.; Bracci, P. M.; Holly, E. A.; Willett, E.; Spinelli, J. J.; La, V. C.; Zheng, T.; Becker, N.; De, S. S.; Chiu, B. C.; Dal, M. L.; Cocco, P.; Maynadie, M.; Foretova, L.; Staines, A.; Brennan, P.; Davis, S.; Severson, R.; Cerhan, J. R.; Breen, E. C.; Birmann, B.; Grulich, A. E.; Cozen, W. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood, 2008, 111(8), 4029-4038.
57. Kassan, S. S.; Thomas, T. L.; Moutsopoulos, H. M.; Hoover, R.; Kimberly, R. P.; Budman, D. R.; Costa, J.; Decker, J. L.; Chused, T. M. Increased risk of lymphoma in sicca syndrome. Ann. Intern. Med., 1978, 89(6), 888-892.
58. Mellemkjaer, L.; Pfeiffer, R. M.; Engels, E. A.; Gridley, G.; Wheeler, W.; Hemminki, K.; Olsen, J. H.; Dreyer, L.; Linet, M. S.; Goldin, L. R.; Landgren, O. Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma. Arthritis Rheum., 2008, 58(3), 657-666.
59. Harris, N. L.; Jaffe, E. S.; Stein, H.; Banks, P. M.; Chan, J. K.; Cleary, M. L.; Delsol, G.; Wolf-Peeters, C.; Falini, B.; Gatter, K. C. A revised european-american classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood, 1994, 84(5), 1361-1392.
60. Royer, B.; Cazals-Hatem, D.; Sibilia, J.; Agbalika, F.; Cayuela, J. M.; Soussi, T.; Maloisel, F.; Clauvel, J. P.; Brouet, J. C.; Mariette, X. Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood, 1997, 90(2), 766-775.
61. Voulgarelis, M.; Tzioufas, A. G.; Moutsopoulos, H. M. Mortality in Sjogren's syndrome. Clin. Exp. Rheumatol., 2008, 26(5 Suppl 51), S66-S71.
62. Hussell, T.; Isaacson, P. G.; Crabtree, J. E.; Spencer, J. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J. Pathol., 1996, 178(2), 122-127.
63. Isaacson, P. G.; Du, M. Q. Gastrointestinal lymphoma: where morphology meets molecular biology. J. Pathol., 2005, 205(2), 255-274.
64. Wohrer, S.; Troch, M.; Raderer, M. Therapy of gastric mucosaassociated lymphoid tissue lymphoma. Expert. Opin. Pharmacother., 2007, 8(9), 1263-1273.
65. Bahler, D. W.; Swerdlow, S. H. Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjogren's syndrome) begin as nonmalignant antigen-selected expansions. Blood, 1998, 91(6), 1864-1872.
66. Gasparotto, D.; De Vita, S.; De, R., V; Marzotto, A.; De Marchi, G.; Scott, C. A.; Gloghini, A.; Ferraccioli, G.; Boiocchi, M. Extrasalivary lymphoma development in Sjogren's syndrome: clonal evolution from parotid gland lymphoproliferation and role of local triggering. Arthritis Rheum., 2003, 48(11), 3181-3186.
67. Bende, R. J.; Aarts, W. M.; Riedl, R. G.; de Jong, D.; Pals, S. T.; van Noesel, C. J. Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J. Exp. Med., 2005, 201(8), 1229-1241.
68. Martin, T.; Weber, J. C.; Levallois, H.; Labouret, N.; Soley, A.; Koenig, S.; Korganow, A. S.; Pasquali, J. L. Salivary gland lymphomas in patients with Sjogren's syndrome may frequently develop from rheumatoid factor B cells. Arthritis Rheum., 2000, 43(4), 908-916.
69. Deutsch, A. J.; Aigelsreiter, A.; Staber, P. B.; Beham, A.; Linkesch, W.; Guelly, C.; Brezinschek, R. I.; Fruhwirth, M.; Emberger, W.; Buettner, M.; Beham-Schmid, C.; Neumeister, P. MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation. Blood, 2006, 109(8), 3500-3504.
70. Bahler, D. W.; Miklos, J. A.; Swerdlow, S. H. Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas. Blood, 1997, 89(9), 3335-3344.
71. Chapman, C. J.; Dunn-Walters, D. K.; Stevenson, F. K.; Hussell, T.; Isaacson, P. G.; Spencer, J. Sequence analysis of immunoglobulin variable region genes that encode autoantibodies expressed by lymphomas of mucosa associated lymphoid tissue. Clin. Mol. Pathol., 1996, 49(1), M29-M32.
72. Du, M.; Diss, T. C.; Xu, C.; Peng, H.; Isaacson, P. G.; Pan, L. Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia, 1996, 10(7), 1190-1197.
73. Qin, Y.; Greiner, A.; Trunk, M. J.; Schmausser, B.; Ott, M. M.; Muller-Hermelink, H. K. Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood, 1995, 86(9), 3528-3534.
74. Mazzucchelli, L.; Blaser, A.; Kappeler, A.; Scharli, P.; Laissue, J. A.; Baggiolini, M.; Uguccioni, M. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma [see comments]. J Clin. Invest., 1999, 104(10), R49-54.
75. Smith, J. R.; Braziel, R. M.; Paoletti, S.; Lipp, M.; Uguccioni, M.; Rosenbaum, J. T. Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. Blood, 2003, 101(3), 815-821.
76. Smith, J. R.; Falkenhagen, K. M.; Coupland, S. E.; Chipps, T. J.; Rosenbaum, J. T.; Braziel, R. M. Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1. Am. J. Clin. Pathol., 2007, 127(4), 633-641.
77. Leadbetter, E. A.; Rifkin, I. R.; Hohlbaum, A. M.; Beaudette, B. C.; Shlomchik, M. J.; Marshak-Rothstein, A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature, 2002, 416(6881), 603-607.
78. Theander, E.; Vasaitis, L.; Baecklund, E.; Nordmark, G.; Warfvinge, G.; Jonsson, E.; Jonsson, M. Germinal center formation in salivary gland biopsies is a new and strong predictor of non-Hodgkin's lymphoma in primary Sjogren's syndrome. Ann. Rheum. Dis., 2010, 69 (SIII).